These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11136352)

  • 21. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
    Federico F; Simone IL; Lucivero V; De Mari M; Giannini P; Iliceto G; Mezzapesa DM; Lamberti P
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):239-42. PubMed ID: 9069478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
    Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased glutamate and deep brain atrophy can predict the severity of multiple sclerosis.
    Polacek H; Kantorova E; Hnilicova P; Grendar M; Zelenak K; Kurca E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):45-53. PubMed ID: 30150790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders.
    Federico F; Simone IL; Lucivero V; Iliceto G; De Mari M; Giannini P; Mezzapesa DM; Tarantino A; Lamberti P
    Mov Disord; 1997 Nov; 12(6):903-9. PubMed ID: 9399213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton MRS in Kennedy disease: absolute metabolite and macromolecular concentrations.
    Mader I; Karitzky J; Klose U; Seeger U; Sperfeld A; Naegele T; Schick F; Ludolph A; Grodd W
    J Magn Reson Imaging; 2002 Aug; 16(2):160-7. PubMed ID: 12203763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced concentrations of N-acetylaspartate (NAA) and the NAA-creatine ratio in the basal ganglia in bipolar disorder: a study using 3-Tesla proton magnetic resonance spectroscopy.
    Frye MA; Thomas MA; Yue K; Binesh N; Davanzo P; Ventura J; O'Neill J; Guze B; Curran JG; Mintz J
    Psychiatry Res; 2007 Apr; 154(3):259-65. PubMed ID: 17346949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker.
    Watanabe H; Fukatsu H; Katsuno M; Sugiura M; Hamada K; Okada Y; Hirayama M; Ishigaki T; Sobue G
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):103-9. PubMed ID: 14707317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An age and gender dependency of metabolite concentrations in basal ganglia in children with spastic diplegia: proton magnetic resonance spectroscopy study.
    Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Zawada B; Otapowicz D
    J Child Neurol; 2009 Jan; 24(1):73-9. PubMed ID: 18936194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
    Baruth JM; Wall CA; Patterson MC; Port JD
    Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study.
    Block W; Bayer TA; Tepest R; Träber F; Rietschel M; Müller DJ; Schulze TG; Honer WG; Maier W; Schild HH; Falkai P
    Neurosci Lett; 2000 Aug; 289(2):147-51. PubMed ID: 10904141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolite concentrations in supraventricular white matter from teenage to early old age: A short echo time 1H magnetic resonance spectroscopy (MRS) study.
    Raininko R; Mattsson P
    Acta Radiol; 2010 Apr; 51(3):309-15. PubMed ID: 20170295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
    Yildiz-Yesiloglu A; Ankerst DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):969-95. PubMed ID: 16677749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical abnormalities in basal ganglia and executive dysfunction in acute- and euthymic-episode patients with bipolar disorder: A proton magnetic resonance spectroscopy study.
    Lai S; Zhong S; Liao X; Wang Y; Huang J; Zhang S; Sun Y; Zhao H; Jia Y
    J Affect Disord; 2018 Jan; 225():108-116. PubMed ID: 28818755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton MRS in acute traumatic brain injury: role for glutamate/glutamine and choline for outcome prediction.
    Shutter L; Tong KA; Holshouser BA
    J Neurotrauma; 2004 Dec; 21(12):1693-705. PubMed ID: 15684761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
    Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
    Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brainstem 1H-MR spectroscopy in patients with Parkinson's disease with REM sleep behavior disorder and IPD patients without dream enactment behavior.
    Hanoglu L; Ozer F; Meral H; Dincer A
    Clin Neurol Neurosurg; 2006 Feb; 108(2):129-34. PubMed ID: 15936138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.